Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 642

1.

Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers' diarrhea.

Lundkvist J, Steffen R, Jönsson B.

J Travel Med. 2009 Jan-Feb;16(1):28-34. doi: 10.1111/j.1708-8305.2008.00270.x. Erratum in: J Travel Med. 2009 Mar-Apr;16(2):147.

2.

Doxycycline prophylaxis of travelers' diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli.

Sack RB, Santosham M, Froehlich JL, Medina C, Orskov F, Orskov I.

Am J Trop Med Hyg. 1984 May;33(3):460-6.

PMID:
6375407
3.

Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.

Jelinek T, Kollaritsch H.

Expert Rev Vaccines. 2008 Jul;7(5):561-7. doi: 10.1586/14760584.7.5.561. Review.

PMID:
18564011
4.

Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.

Leyten EM, Soonawala D, Schultsz C, Herzog C, Ligthelm RJ, Wijnands S, Visser LG.

Vaccine. 2005 Oct 17;23(43):5120-6.

PMID:
15982790
5.

Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea.

López-Gigosos R, Garcia-Fortea P, Calvo MJ, Reina E, Diez-Diaz R, Plaza E.

BMC Infect Dis. 2009 May 16;9:65. doi: 10.1186/1471-2334-9-65.

6.

Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.

López-Gigosos R, García-Fortea P, Reina-Doña E, Plaza-Martín E.

Travel Med Infect Dis. 2007 Nov;5(6):380-4.

PMID:
17983977
7.

Effectiveness of the WC/rBS oral cholera vaccine in the prevention of traveler's diarrhea: a prospective cohort study.

López-Gigosos R, Campins M, Calvo MJ, Pérez-Hoyos S, Díez-Domingo J, Salleras L, Azuara MT, Martínez X, Bayas JM, Ramón Torrell JM, Pérez-Cobaleda MA, Núñez-Torrón ME, Gorgojo L, García-Rodríguez M, Díez-Díaz R, Armadans L, Sánchez-Fernández C, Mejías T, Masuet C, Pinilla R, Antón N, Segarra P.

Hum Vaccin Immunother. 2013 Mar;9(3):692-8.

8.

Safety, Immunogenicity, and Protective Efficacy of the Whole-Cell/Recombinant B Subunit (WC/rBS) Oral Cholera Vaccine Against Travelers' Diarrhea.

Scerpella EG, Sanchez JL, Mathewson III JJ, Torres-Cordero JV, Sadoff JC, Svennerholm AM, DuPont HL, Taylor DN, Ericsson CD.

J Travel Med. 1995 Mar 1;2(1):22-27.

9.

Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study.

Meraz IM, Jiang ZD, Ericsson CD, Bourgeois AL, Steffen R, Taylor DN, Hernandez N, DuPont HL.

J Travel Med. 2008 Nov-Dec;15(6):412-8. doi: 10.1111/j.1708-8305.2008.00249.x.

10.

Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial.

Clemens JD, Sack DA, Harris JR, Chakraborty J, Neogy PK, Stanton B, Huda N, Khan MU, Kay BA, Khan MR, et al.

J Infect Dis. 1988 Aug;158(2):372-7.

PMID:
3042876
12.

Travelers' diarrhea: microbiologic bases for prevention and treatment.

Sack RB.

Rev Infect Dis. 1990 Jan-Feb;12 Suppl 1:S59-63. Review.

PMID:
2406857
14.

[Examples for vaccines against diarrheal diseases--rotavirus and traveller's diarrhea].

Kollaritsch H, Wiedermann U.

Wien Med Wochenschr. 2007;157(5-6):102-6. Review. German.

PMID:
17427005
15.

Vaccines against traveler's diarrhoea and rotavirus disease - a review.

Wiedermann U, Kollaritsch H.

Wien Klin Wochenschr. 2006;118(19-20 Suppl 3):2-8. Review.

PMID:
17131234
16.

Vaccines against enterotoxigenic Escherichia coli.

Svennerholm AM, Tobias J.

Expert Rev Vaccines. 2008 Aug;7(6):795-804. doi: 10.1586/14760584.7.6.795. Review.

PMID:
18665777
17.

Prevention of fecal-orally transmitted diseases in travelers through an oral anticholeric vaccine (WC/rBS).

Gabutti G, Aquilina M, Cova M, Giuffrida S, Lizioli A, Protano D, Scrivano F, Tomasi A, Cucchi A, Cavallaro A; Collaborative Group for the Study of Fecal-Orally Transmitted Diseases in Travelers..

J Prev Med Hyg. 2012 Dec;53(4):199-203.

PMID:
23469588
18.

Enterotoxigenic Escherichia coli virulence factors and vaccine approaches.

Sizemore DR, Roland KL, Ryan US.

Expert Rev Vaccines. 2004 Oct;3(5):585-95. Review.

PMID:
15485338
19.

Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico.

Bouckenooghe AR, Jiang ZD, De La Cabada FJ, Ericsson CD, DuPont HL.

J Travel Med. 2002 May-Jun;9(3):137-40.

20.

Oral cholera vaccine--for whom, when, and why?

Topps MH.

Travel Med Infect Dis. 2006 Jan;4(1):38-42. Review.

PMID:
16887724
Items per page

Supplemental Content

Support Center